# O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus

> **NCT04440566** · NA · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 50 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **BIOLOGICAL:** blood sample

## Key facts

- **NCT ID:** NCT04440566
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-13
- **Primary completion:** 2022-02-14
- **Final completion:** 2022-02-14
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04440566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04440566, "O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04440566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*